AstraZeneca may cut UK jobs if a biodiversity profit levy is introduced
The Guardian - 25-Oct-2024UK is considering enforcing these profit-sharing measures nationally
Join the club for FREE to access the whole archive and other member benefits.
UK is considering enforcing these profit-sharing measures nationally
AI unlocks new insights into the complexities of the immune system
Clinical trials for the ageing drug could potentially be completed in 3-6 years
Genetika+ tests drugs against a patient's own cells; Insilico Medicine is slashing the time taken for drug discovery
ProGen AI designs artificial enzymes, revolutionizing protein engineering and biotechnology
An automated sense-check of publications sounds like a good idea
Insilico Medicine is slashing the cost of drug development
When treating a female patient consider how significant sex differences can be
They are laying off staff now as their profits are not as high as before
Partnering with Japan's DSP, a milestone is reached in OCD treatment
Body-on-Chips platform is created by connecting 10 organ-chips to mimic normal human blood flow
The more people looking at clever new ways to beat cancer the better
Multimorbidity + polypharmacy = too many combinations to test
Monopolist Aspen got the opportunity to raise the price of essential NHS medicine by 1,800 per cent
Old drugs are just as good as those new drugs - pharmaceutical mafia in action
Inflated prices of more than 100 generic drugs by as much as 1000 per cent
The high rate of alerts and warnings maybe the result of post-approval monitoring
FDA only just sits back and watch as people succumb to this opioid crisis
Preventing overmedication may lead to reduced death rates and hospital admissions
Discovery of new cardiovascular medicines at lowest point in decades.
Researchers developed an algorithm to test whether drugs are likely to undergo racemisation.
US physicians often fail to mention that they have accepted thousands of dollars from the companies that make the prescription drugs they tout.
King’s Fund health think tank claims there is a systemic lack of transparency in the information being given to doctors.
The study was published in the Health Affairs journal.